CN Bio’s PhysioMimix adopted by King’s College London to investigate chronic liver disease
The next-generation organ-on-a-chip technology to be used to investigate the human gut microbiome for improving outcomes for patients with liver cirrhosis
The next-generation organ-on-a-chip technology to be used to investigate the human gut microbiome for improving outcomes for patients with liver cirrhosis
Collaboration aims to provide new workflows, faster acquisition speeds and deeper resolution
Panbio COVID-19 Antigen Self-Test is approved for sale directly to consumers, enabling fast, convenient coronavirus testing
The Panbio self-test features a minimally invasive nasal swab and delivers results in as early as 15 minutes with no instrumentation, using proven Abbott lateral flow technology
Seward has launched the first sterile paddle blender bag that can also be autoclaved, reduces processing time, labor costs and plastic waste.
Offing end-to-end automation processes and technologies for electrification
The integrated platform from industry leaders will remove complexities in the patient journey to benefit all clinical trial stakeholders
The facility will be capable of manufacturing batches ranging from those for early-stage research to GMP for clinical and future commercial uses
The industry-recognized state-of-the-art secondary packaging format is now available
Watch this on-demand webinar to understand the key considerations for selecting culture media products
Watch this on-demand webinar to learn about innovative lab solutions to support your experimental success
EPISEQ SARS-COV-2 will support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants
This open access tool, powered by data supplied by GISAID, provides virologists and COVID-19 test developers insight to the latest viral variants and primer designs used around the world
Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations